Order Article Reprints

Roth GS, Benhamou M, Teyssier Y, Seigneurin A, Abousalihac M, Sengel C, Seror O, Ghelfi J, Ganne-Carrié N, Blaise L, et al. Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers. 2021; 13(4):812. https://doi.org/10.3390/cancers13040812

Roth, Gaël S., Maxime Benhamou, Yann Teyssier, Arnaud Seigneurin, Mélodie Abousalihac, Christian Sengel, Olivier Seror, Julien Ghelfi, Nathalie Ganne-Carrié, Lorraine Blaise, and et al. 2021. "Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis" Cancers 13, no. 4: 812. https://doi.org/10.3390/cancers13040812

Roth, G. S., Benhamou, M., Teyssier, Y., Seigneurin, A., Abousalihac, M., Sengel, C., Seror, O., Ghelfi, J., Ganne-Carrié, N., Blaise, L., Sutter, O., Decaens, T., & Nault, J. -C. (2021). Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers, 13(4), 812. https://doi.org/10.3390/cancers13040812